{"id":517969,"date":"2021-07-27T07:04:26","date_gmt":"2021-07-27T11:04:26","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/"},"modified":"2021-07-27T07:04:26","modified_gmt":"2021-07-27T11:04:26","slug":"cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/","title":{"rendered":"Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p \/>\n<p>\n        <span class=\"xn-location\">CAMBRIDGE, Mass.<\/span> and <span class=\"xn-location\">BOULDER, Colo.<\/span>, July\u00a027, 2021 \/PRNewswire\/ &#8212;\u00a0Cogent Biosciences, Inc.\u00a0(Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that <span class=\"xn-person\">Andrew Robbins<\/span>, Chief Executive Officer and President, will present at the Wedbush PacGrow Healthcare Conference on <span class=\"xn-chron\">Tuesday, August 10<\/span><sup>th<\/sup>, from <span class=\"xn-chron\">10:55 -11:25am ET<\/span>.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1306930\/Cogent_Biosciences_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1306930\/Cogent_Biosciences_Logo.jpg\" title=\"(PRNewsfoto\/Cogent Biosciences, Inc.)\" alt=\"(PRNewsfoto\/Cogent Biosciences, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Access to the webcast of this event, as well as an archived recording, will be available under the &#8220;Events&#8221; tab on the investor relations section of the Cogent Biosciences website at: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3239956-1&amp;h=827168450&amp;u=https%3A%2F%2Finvestors.cogentbio.com%2Fevents&amp;a=https%3A%2F%2Finvestors.cogentbio.com%2Fevents\" rel=\"nofollow noopener\">https:\/\/investors.cogentbio.com\/events<\/a>. <\/p>\n<p>\n        <b>About Cogent Biosciences, Inc.<\/b>\u00a0<br \/>Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving systemic mastocytosis, a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. In addition to bezuclastinib, the newly formed Cogent Research team is developing a portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases. Cogent Biosciences is based in <span class=\"xn-location\">Cambridge, MA<\/span> and <span class=\"xn-location\">Boulder, Co.<\/span> Visit our website for more information at <a target=\"_blank\" href=\"\/\/egnytedrive\/Users\/lizamoore\/.webedit\/T1AOLF\/www.cogentbio.com\" rel=\"nofollow noopener\">www.cogentbio.com<\/a>. Follow Cogent Biosciences on social media: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3239956-1&amp;h=721449229&amp;u=https%3A%2F%2Ftwitter.com%2FCogentBio&amp;a=Twitter\" rel=\"nofollow noopener\">Twitter<\/a>\u00a0and <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3239956-1&amp;h=1059711911&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fcogentbiosciences%2F&amp;a=LinkedIn.\" rel=\"nofollow noopener\">LinkedIn.<\/a> Information that may be important to investors will be routinely posted on our website and Twitter. <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH55274&amp;sd=2021-07-27\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021-301341731.html\">https:\/\/www.prnewswire.com\/news-releases\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021-301341731.html<\/a><\/p>\n<p>SOURCE  Cogent Biosciences, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=PH55274&amp;Transmission_Id=202107270700PR_NEWS_USPR_____PH55274&amp;DateId=20210727\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire CAMBRIDGE, Mass. and BOULDER, Colo., July\u00a027, 2021 \/PRNewswire\/ &#8212;\u00a0Cogent Biosciences, Inc.\u00a0(Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that Andrew Robbins, Chief Executive Officer and President, will present at the Wedbush PacGrow Healthcare Conference on Tuesday, August 10th, from 10:55 -11:25am ET. Access to the webcast of this event, as well as an archived recording, will be available under the &#8220;Events&#8221; tab on the investor relations section of the Cogent Biosciences website at: https:\/\/investors.cogentbio.com\/events. About Cogent Biosciences, Inc.\u00a0Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor that is designed to potently inhibit &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-517969","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire CAMBRIDGE, Mass. and BOULDER, Colo., July\u00a027, 2021 \/PRNewswire\/ &#8212;\u00a0Cogent Biosciences, Inc.\u00a0(Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that Andrew Robbins, Chief Executive Officer and President, will present at the Wedbush PacGrow Healthcare Conference on Tuesday, August 10th, from 10:55 -11:25am ET. Access to the webcast of this event, as well as an archived recording, will be available under the &#8220;Events&#8221; tab on the investor relations section of the Cogent Biosciences website at: https:\/\/investors.cogentbio.com\/events. About Cogent Biosciences, Inc.\u00a0Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor that is designed to potently inhibit &hellip; Continue reading &quot;Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-27T11:04:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1306930\/Cogent_Biosciences_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021\",\"datePublished\":\"2021-07-27T11:04:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\\\/\"},\"wordCount\":281,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1306930\\\/Cogent_Biosciences_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\\\/\",\"name\":\"Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1306930\\\/Cogent_Biosciences_Logo.jpg\",\"datePublished\":\"2021-07-27T11:04:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1306930\\\/Cogent_Biosciences_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1306930\\\/Cogent_Biosciences_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/","og_locale":"en_US","og_type":"article","og_title":"Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021 - Market Newsdesk","og_description":"PR Newswire CAMBRIDGE, Mass. and BOULDER, Colo., July\u00a027, 2021 \/PRNewswire\/ &#8212;\u00a0Cogent Biosciences, Inc.\u00a0(Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that Andrew Robbins, Chief Executive Officer and President, will present at the Wedbush PacGrow Healthcare Conference on Tuesday, August 10th, from 10:55 -11:25am ET. Access to the webcast of this event, as well as an archived recording, will be available under the &#8220;Events&#8221; tab on the investor relations section of the Cogent Biosciences website at: https:\/\/investors.cogentbio.com\/events. About Cogent Biosciences, Inc.\u00a0Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor that is designed to potently inhibit &hellip; Continue reading \"Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-27T11:04:26+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1306930\/Cogent_Biosciences_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021","datePublished":"2021-07-27T11:04:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/"},"wordCount":281,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1306930\/Cogent_Biosciences_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/","name":"Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1306930\/Cogent_Biosciences_Logo.jpg","datePublished":"2021-07-27T11:04:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1306930\/Cogent_Biosciences_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1306930\/Cogent_Biosciences_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cogent-biosciences-to-present-at-wedbush-pacgrow-virtual-healthcare-conference-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517969","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=517969"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517969\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=517969"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=517969"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=517969"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}